VRCA FY 2022 Earnings — Verrica Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

VRCAVerrica Pharmaceuticals Inc.

$56M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$9M-24.7% YoY

Gross Profit

$8M92.0% margin

Operating Income

-$21M-235.8% margin

Net Income

-$24M-271.1% margin

EPS (Diluted)

$-7.17

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$19M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$45M

Total Liabilities

$5M

Stockholders' Equity

$40M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	$12M	-24.7%
Gross Profit	$8M	$12M	-27.9%
Operating Income	-$21M	-$31M	+31.1%
Net Income	-$24M	-$35M	+30.2%